Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Urine glucose tetrasaccharide:...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort

Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort

Bibliographic Details
Main Authors: Monique Piraud, Magali Pettazzoni, Marie de Antonio, Christine Vianey-Saban, Roseline Froissart, Brigitte Chabrol, Sarah Young, Pascal Laforêt
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Molecular Genetics and Metabolism Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S221442692030029X
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S221442692030029X

Similar Items

  • Glucose-6-phosphatase deficiency
    by: Labrune Philippe, et al.
    Published: (2011-05-01)
  • LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
    by: Magali Pettazzoni, et al.
    Published: (2017-01-01)
  • P188: Urine glucose tetrasaccharide as a potential pharmacodynamic biomarker for the development of new treatments for glycogen storage disease type III*
    by: Rachael Hawtin, et al.
    Published: (2023-01-01)
  • Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)
    by: Tomàs Pinós, et al.
    Published: (2020-10-01)
  • French recommendations for the management of glycogen storage disease type III
    by: Camille Wicker, et al.
    Published: (2023-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs